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Abstract
Background: Persons with congestive heart failure may be at higher risk of the acute effects related to daily
fluctuations in ambient air pollution. To meet some of the limitations of previous studies using grouped-analysis, we
developed a cohort study of persons with congestive heart failure to estimate whether daily non-accidental mortality
were associated with spatially-resolved, daily exposures to ambient nitrogen dioxide (NO2) and ozone (O3), and
whether these associations were modified according to a series of indicators potentially reflecting complications or
worsening of health. Methods: We constructed the cohort from the linkage of administrative health databases. Daily
exposure was assigned from different methods we developed previously to predict spatially-resolved, time-dependent
concentrations of ambient NO2 (all year) and O3 (warm season) at participants’ residences. We performed time-
stratified case-crossover and nested case-control analyses that provide two different epidemiological parameters of
effect: the case-crossover design contrasts the same person at different times, and the nested case-control design
contrasts different persons at similar times. We modelled the effects of air pollution and weather (case-crossover only)
on mortality using distributed lag nonlinear models over lags 0 to 3 days. We developed from administrative health
data a series of indicators that may reflect the underlying construct of “declining health”, and used interactions
between these indicators and the cross-basis function for air pollutant to assess potential effect modification. Results:
The magnitude of the cumulative as well as the lag-specific estimates of association differed in many instances
according to the metric of exposure. Using the back-extrapolation method, which is our preferred exposure model, we
found for the case-crossover design a cumulative mean percentage changes (MPC) in daily mortality per interquartile
increment in NO2 (8.8 ppb) of 3.0% (95% CI: -0.9, 6.9%) and for O3 (16.5 ppb) 3.5% (95% CI: -4.5, 12.1). For O3
there was strong confounding by weather (unadjusted MPC = 7.1%; 95%CI: 1.7, 12.7%). For the nested case-control
approach the cumulative MPC for NO2 in daily mortality was 2.9 % (95% CI: -0.9, 6.9%) and for O3 7.3% (95% CI:
3.0, 11.9%). We found evidence of effect modification between daily mortality and cumulative NO2 and O3 according
to the prescribed dose of furosemide in the nested case-control analysis, but not in the case-crossover analysis.
Conclusions: Mortality in congestive heart failure was associated with exposure to daily ambient NO2 and O3
predicted from a back-extrapolation method using a land use regression model from dense sampling surveys. The
methods used to assess exposure can have considerable influence on the estimated acute health effects of the two air
pollutants.
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ABSTRACT
Background: Persons with congestive heart failure may be at higher risk of the acute effects 
related to daily fluctuations in ambient air pollution.  To meet some of the limitations of previous 
studies using grouped-analysis, we developed a cohort study of persons with congestive heart 
failure to estimate whether daily non-accidental mortality were associated with spatially-resolved, 
daily exposures to ambient nitrogen dioxide (NO2) and ozone (O3), and whether these 
associations were modified according to a series of indicators potentially reflecting complications 
or worsening of health. 
Methods: We constructed the cohort from the linkage of administrative health databases. Daily 
exposure was assigned from different methods we developed previously to predict spatially-
resolved, time-dependent concentrations of ambient NO2 (all year) and O3 (warm season) at 
participants’ residences. We performed time-stratified case-crossover and nested case-control 
analyses that provide two different epidemiological parameters of effect: the case-crossover 
design contrasts the same person at different times, and the nested case-control design contrasts 
different persons at similar times. We modelled the effects of air pollution and weather (case-
crossover only) on mortality using distributed lag nonlinear models over lags 0 to 3 days. We 
developed from administrative health data a series of indicators that may reflect the underlying 
construct of “declining health”, and used interactions between these indicators and the cross-basis 
function for air pollutant to assess potential effect modification.
Results: The magnitude of the cumulative as well as the lag-specific estimates of association 
differed in many instances according to the metric of exposure. Using the back-extrapolation 
method, which is our preferred exposure model, we found for the case-crossover design a 
cumulative mean percentage changes (MPC) in daily mortality per interquartile increment in NO2  
(8.8 ppb) of 3.0% (95% CI: -0.9, 6.9%) and for O3 (16.5 ppb) 3.5% (95% CI: -4.5, 12.1). For O3 
there was strong confounding by weather (unadjusted MPC = 7.1%; 95%CI: 1.7, 12.7%). For the 
nested case-control approach the cumulative MPC for NO2 in daily mortality was 2.9 % (95% CI: 
-0.9, 6.9%) and for O3 7.3% (95% CI: 3.0, 11.9%). We found evidence of effect modification 
between daily mortality and cumulative NO2 and O3 according to the prescribed dose of 
furosemide in the nested case-control analysis, but not in the case-crossover analysis.
Conclusions: Mortality in congestive heart failure was associated with exposure to daily ambient 
NO2 and O3 predicted from a back-extrapolation method using a land use regression model from 
dense sampling surveys. The methods used to assess exposure can have considerable influence on 
the estimated acute health effects of the two air pollutants.  
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control; case-crossover; nitrogen dioxide; ozone.
 
Funding: Stephane Buteau was supported by the Canadian Institute for Health Research 
(Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarship 
(201310GSD)). Dr. Gasparrini was supported by a research grant from the Medical Research 
Council, UK (Grant ID: MR/M022625/1).
Conflict of interest: none declared.















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1List of Figures 
Figure 1. Estimated percentage change in daily non-accidental mortality among subjects 65 years 
of age and over with congestive heart failure according to the interquartile range in daily 24-hour 
mean exposures to ambient NO2 (all year) from different spatiotemporal methods to predict 
concentrations and type of analysis, Montreal, 1991–2003. 
Figure 2. Estimated percentage change in daily non-accidental mortality among subjects 65 years 
of age and over with congestive heart failure according to the interquartile range in daily 8-hour 
mean exposures to ambient O3 (May-September) from different spatiotemporal methods to predict 
concentrations and type of analysis, Montreal, 1991–2003.  
Figure 3. Estimated cumulative percentage change in the (A) nested case-control and, (B) case-
crossover analysis on the risks of non-accidental mortality per interquartile range increase in daily 
mean 24-hour mean exposures to ambient NO2 (all year) and, daily 8-hour mean exposures to 
ambient O3 (May-September), according to the prescribed dose of furosemide. 
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Figure 1. Estimated percentage change in daily non-accidental mortality among subjects 65 years of 
age and over with congestive heart failure according to the interquartile range in daily 24-hour 
mean exposures to ambient NO2 (all year) from different spatiotemporal methods to predict 
concentrations and type of analysis, Montreal, 1991–2003. Interquartile ranges (IQRs) were 13.6, 10.0, 
8.8 and 9.6 ppb for the nearest station approach (“Nearest station”), inverse-distance weighting (“IDW”), 
back-extrapolation from a land use regression (“LUR back-extrapol.”), and the daily mean across all 
stations (“Mean of stations”), respectively.  Numbers on the horizontal axis denote single day lags (0 to 3) 
and the cumulative for these lags (“cumul.”). Dots represent maximum likelihood estimates and bars 
represent 95% confidence intervals. In both type of analysis NO2 was fitted from a distributed lag non-
linear model accumulated over lags 0 to 3 days using a linear structure for NO2 and an unconstrained 
structure for lags. In the case-crossover analyses, time invariant factors and temporal trends were 
controlled by design and we statistically adjusted for maximum temperature (natural cubic spline with 3 
df), and relative humidity (linear), from a distributed lag non-linear model accumulated over lags 0 to 3 
days. In the nested case-control analyses, we adjusted for age (natural cubic splines with 3 df), sex, and 
area-based indicators of socio-economic status including median household income (natural cubic splines 
with 3 df), unemployment rate among adults (natural cubic splines with 3 df), and percent of adults 
without high school diploma (linear). We could not in the nested case-control analyses estimate the mean 
of all stations, as this metric does not have any variability between individuals. 
 
3Figure 2. Estimated percentage change in daily non-accidental mortality among subjects 65 years of 
age and over with congestive heart failure according to the interquartile range in daily 8-hour mean 
exposures to ambient O3 (May-September) from different spatiotemporal methods to predict 
concentrations and type of analysis, Montreal, 1991–2003.  Interquartile ranges (IQRs) were 19.6, 16.6, 
16.4, 11.6 and 11.8 ppb for the nearest station approach (“Nearest station”), inverse-distance weighting 
(“IDW”), back-extrapolation from a land use regression (“LUR back-extrapol.”), Bayesian maximum 
entropy model (“BME”) and the daily mean across all stations (“Mean of stations”), respectively. We 
present results for the case-crossover adjusting (“Adj. Case-crossover”) and not adjusting for weather 
(“Unadj. Case-crossover”). Numbers on the horizontal axis denote single day lags (0 to 3) and the 
cumulative for these lags (“cumul.”). Dots represent maximum likelihood estimates and bars represent 
95% confidence intervals. In both types of analyses, O3 was fitted from a distributed lag non-linear model 
accumulated over lags 0 to 3 days using a linear function for O3 and an unconstrained structure for lags. In 
the nested case-control analysis, we adjusted for age (natural cubic splines with 3 df), sex, and area-based 
indicators of socio-economic status including: median household income (natural cubic splines with 3 df; 
unemployment rate among adults (natural cubic splines with 3 df); and percent of adults without high 
school diploma (linear). The case-crossover controlled for time invariant factors and temporal trend by 
design and in the adjusted model (“Adj. Case-crossover”) we statistically adjusted for maximum 
temperature (natural cubic spline with 3 df), and relative humidity (linear), from a distributed lag non-
linear model accumulated over lags 0 to 3 days. We could not in the nested case-control analyses estimate 
the mean of all stations, as this metric does not have any variability between individuals.
4(A)
(B) 
Figure 3. Estimated cumulative percentage change in the (A) nested case-control and, (B) case-
crossover analysis on the risks of non-accidental mortality per interquartile range increase in daily 
24-hour mean exposures to ambient NO2 (all year) and, daily 8-hour mean exposures to ambient O3 
(May-September), according to the prescribed dose of furosemide. Dots represent maximum 
likelihood estimates and bars represent 95% confidence intervals. For O3, we present results adjusting 
5(“O3-Adj.”) and not adjusting for weather (“O3-Unadj.”). The horizontal axis indicates the different 
categories based on the dose of furosemide, with “Others” defining people who were not taking 
furosemide. We did not develop the BME model for NO2. For NO2, interquartile ranges (IQRs) were 13.6, 
10.0, 8.8 and 9.6 ppb for the nearest station approach (“Nearest station”), inverse-distance weighting 
(“IDW”), back-extrapolation from a land use regression (“LUR back-extrapol.”), and the daily mean 
across all stations (“Mean of stations”), respectively. For O3, IQRs were 19.6, 16.6, 16.4, 11.6 and 11.8 
ppb for the nearest station, IDW, LUR back-extrapol., BME and mean of stations, respectively. 
List of Tables 
Table 1. Description of the cohort of persons 65 years of age and older having congestive heart 
failure in Montreal, 1991-2003. 
Table 2. Prevalence of selected important comorbidities at time of entry in the cohort among 
persons 65 years of age and older having congestive heart failure in Montreal, 1991-2003.  
Table 1. Description of the cohort of persons 65 years of age and older having congestive heart failure in 
Montreal, 1991-2003 
Women Men All 
Number of persons included in the cohort 37,587 25,947 63,534
Mean (SD) age at entry in the cohort 75.8 (6.9) 78.1 (7.4) 77.2 (7.3) 
No. of deaths 14,062 17,645 31,707
Mean (SD) age at death (in years) 79.9 (7.2) 83.2 (7.6) 81.7 (7.6) 
Furosemide (Lasix) usage at time of death
Not taking furosemide 6,560 (60%) 4,394 (40%) 10,954
Mild dose (0-40 mg) 8,843 (55%) 7,203 (45%) 16,046 
Moderate dose (41-80 mg) 2,094 (48%) 2,274 (52%) 4,368 
High dose (>80 mg or intravenous or oral solution) 148 (44%) 191 (56%) 339
Percentiles
5th 25th 50th 75th 95th 99th
Number of selected important health conditions at 
entry in the cohort1 0 1 1 2 4 6
Number of hospitalisations and emergency 
department visits during follow-up
No. of hospitalisation and emergency visits 
in the last 3 months 0 0 1 2 5 8
No. of hospitalisation and emergency visits 
in the last 6 months 0 0 1 2 6 10
No. of hospitalisation during the whole follow-up 0 0 1 2 6 11
Abbreviation: SD, standard deviation.
1Refer to Appendix Table C2 for the list of selected important comorbidities and the algorithms used for 
each condition.
Table 2. Prevalence of selected important comorbidities at time of entry in the cohort among persons 65 
years of age and older having congestive heart failure in Montreal, 1991-20031  
Comorbidities Prevalence (%) 
Myocardial infarction 19.0%
Chronic pulmonary disease 18.9%
Diabetes without chronic complication 17.3%
Cerebrovascular disease 13.3%
Peripheral vascular disease 11.4%
Renal disease 10.5%
Any malignancy, including lymphoma and leukemia, 
except malignant neoplasm of skin 7.3%
Peptic ulcer disease 4.4%
Diabetes with chronic complication 4.1%
Dementia 3.5%
Hemiplegia or paraplegia 3.0%
Mild liver disease 2.2%
Rheumatic disease 1.7%
Metastatic solid tumor 1.5%
Moderate or severe liver disease 0.4%
AIDS/HIV <0.1%
1Comorbidities were identified from primary and secondary diagnoses from hospital discharge data based 
on the Enhanced ICD-9-CM diagnosis coding algorithms. Please refer to Appendix Table C2 for the 
coding algorithms used to define each comorbid condition. 
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Figure E9. Estimated cumulative percentage change, over lag 0-3 day, in non-accidental 
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September), according to the number of hospitalisations and emergency room visits in the 
past six months. 
Figure E10. Estimated cumulative percentage change in non-accidental daily mortality 
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September), by gender. 
Appendix F. Example of R code
6Appendix A. Parameters estimated by the nested case-control and 
case-crossover designs
In both models that we used in this study (nested case-control, and case-crossover), we made use 
of the Cox proportional hazards model, which is essentially equivalent to a conditional logistic 
model. 
The regression coefficients (or smoothed functions) in each design are estimated consistently 
with alternative definitions of the risk sets, thus providing two parameters of effects with distinct 
inferential interpretation. To see this explicitly, we appeal to the partial likelihood function of the 
Cox model. 
Let Yi = I(xi>u), for ith individual at risk at time=u.
For one covariate that is assumed to be either a linear or a categorical variable, the partial log-
likelihood is
l(β)= Σ{all grid points u} [dN(u) { zI(u) β -  log [ΣI exp(ziβ)Yi(u)] }]
where β is the parameter being estimated and zi  is the exposure for subject i. 
In the nested case-control study, i in the last sum represents different subjects in each risk set, 
which implies that the parameter β that is being estimated represents the log rate ratio for an 
increase in exposure, across subjects in each risk sets, summed across all failures. It is assumed 
that the underlying rate ratio is invariant in time (proportional hazards assumption) and assumes 
independent censoring. 
In the case-crossover design, the risk set at each failure now comprises only the case. Thus, zI 
represents the exposure of the case at two sets of times; one at the time of the event and the other 
at the set of selected reference times.  The last sum is therefore over the failure time of the case 
and his own exposure reference times.  This is then summed over all failures. Thus, β represents 
an estimate of the within-subject log rate ratio, assuming that there exists a common log rate ratio 
for each failure. Thus, this is an estimate of the within-subject log rate ratio for a change in 
exposure. 
7Appendix B. Addition information about the construct of the cohort 
of congestive heart failure, Montreal, 1991-2003
This is an open cohort of men and women, 65 years of age and older, residing in Montreal and 
classified as having congestive heart failure during the study period of January 1st, 1991 to 
December 31st, 2002. The date of initiating the cohort was January 1, 1991. The cohort was 
constructed as follows. Individuals were considered as having congestive heart failure at baseline 
if they met our definitions (see Table B1 for the algorithms used to define congestive heart 
failure) in the two years prior to January 1, 1991. Persons who were resident of Montreal and age 
65 years and older, who were identified as having congestive heart failure, and who were not 
censored (due to death or moving outside of the Montreal area) during the definition period were 
entered into the cohort. The same pattern was repeated every two years, i.e., new subjects entered 
the cohort on January 1 every two years if they were classified as having congestive heart failure 
sometime in the two preceding years and met the study inclusion criteria. The last sub-cohort was 
entered on January 1, 2001, thus leaving a potential of two years of follow-up for this last sub-
cohort, as the follow-up ended for all non-censored subjects on December 31, 2002. Those 
entering the cohort were followed until death, migration out of the Montreal area, or termination 
of follow-up. The cohort was dynamic and because of the information about residential locations 
was time-varying, it allowed for a person who moved out of Montreal to re-enter the cohort later 
if they moved back into the study area. 
Figure A1 shows the Island of Montreal, the boundaries of the three-character postal code 
districts from the 2001 Census Boundary Files, as well as the distribution of the number of 
death among persons 65 years and older during the study period of 1991-2002, inclusively. 
Figure A2 shows the schematic of the study design.
8Figure B1. Map of Montreal showing the boundaries of the geographic units designated by the 
first three characters of the postal code, location of highways (bold black lines), and the spatial 
distribution of deaths among persons age 65 years and older having congestive heart failure, 
1991-2003.
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Figure B2. Schematic of the cohort study design of congestive heart failure, Montreal, 1991-
2002. 
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Appendix C. Algorithms used to define congestive heart failure and 
other important comorbidities
Table C1. Algorithm used to define congestive heart failure from administrative health data1. 
Diagnoses (ICD-9 














Services / tests 




Definition 1: None None > 1 prescription 
for diuretics 
AND > 1 
prescription for 
Digoxine 
> 1 CHF 
Definition 2: None None > 1 prescription 
for diuretics 
AND > 1 
prescription for 
ACE-inhibitors 
> 1 CHF 
Definition 3: None > 1 CHF 
(Any MD)
None None
1We identified congestive heart failure diagnoses and procedures using the International Classification of 
Diseases (ICD), 9th Revision codes, specifically ICD-9 428 for diagnosis and codes 8303, 8305, 8307, and 
8670 for procedures.
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Table C2. Coding Algorithms and weights used for defining comorbidity from hospital discharge data 
using International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM).
Comorbidities Enhanced ICD-9-CM coding used to define comorbidity1
Myocardial infarction 410, 412 
Congestive heart failure 428 (see Table A1 for the exact algorithms used)
Peripheral vascular disease 0930, 4373, 440, 441, 4431, 4432, 4438, 4439, 4471, 5571, 5579, V434
Cerebrovascular disease 430, 431, 432, 433, 434, 435, 436, 437, 438 
Dementia   290, 2941, 3312 
Chronic pulmonary disease  4168, 4169, 490, 491, 492, 493, 494, 495, 496, 500, 501, 502, 503, 504, 505, 
5064, 5081, 5088 
Rheumatic disease 4465, 7100, 7101, 7102, 7103, 7104, 7140, 7141, 7142, 7148, 725 
Peptic ulcer disease  531, 532, 533, 534 
Mild liver disease  570, 571, 5733, 5734, 5738, 5739, V427 
Diabetes without chronic 
complication 
2500, 2501, 2502, 2503, 2508, 2509 
Diabetes with chronic complication 2504, 2505, 2506, 2507 
Hemiplegia or paraplegia 3341, 342, 343, 3440, 3441, 3442, 3443, 3444, 3445, 3446, 3449 
Renal disease 582, 5830, 5831, 5832, 5834, 5836, 5837, 585, 586, 5880, V420, V451, V56 
Cancer  140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 
156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 170, 171, 172, 174, 175, 176, 
179, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 191, 192, 193, 194, 
195, 200, 201, 202, 203, 204, 205, 206, 207, 208, 2386 
Moderate or severe liver disease  4560, 4561, 4562, 5722, 5723, 5724, 5728 
Metastatic solid tumor  196, 197, 198, 199 
AIDS/HIV  042, 043, 044 
1 Based on Quan, H., et al., 2005. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 
administrative data. Med Care. 43, 1130-9.
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Appendix D. Development of indicators if health in older adults with 
congestive heart failure 
Individuals having congestive heart failure have different natural histories. We presumed that 
exogenous insults interfere in the potential causal pathway linking air pollution and mortality by 
either “triggering” declines in health or causing exacerbations of concurrent conditions. As there 
is no gold standard by which to define indicators of “health”, we have developed a series of 
possible indices that may reflect the underlying construct of “declining health” from the 
administrative health data, including hospital discharge, billings, pharmaceutical prescriptions. 
The following describe four indicators that we developed from the administrative health data.
Indicators of hospitalisations and emergency department visits
First we used the combined number of hospitalisations and emergency department visits. We 
created two indices reflecting the cumulative number in the three months and in the six months 
before an event. (Events refer to either a death of the subject or being included in a risk set for 
other deaths.) The underlying assumption was that each hospitalisation and emergency 
department visit potentially reflected a complication or worsening in a person’s health. If a 
patient’s record included more than one hospitalisation or emergency room visit on a single day, 
these were counted as one event. Because the distributions were highly skewed to the right and 
we were concerns that some very high values may be wrong (see Table D1 for the distributions) 
the indicators were treated as ordinal, with all cumulative counts greater than the 99th percentile 
of the marginal distribution (i.e., 8 and 10 for the indicator based in the prior three and six 
months, respectively) rounded to this value. Therefore, the indicators based on number of 
hospitalisations and emergency department visits in the past three and six months had nine 
(taking values from 0 to 8) and eleven (taking values from 0 to 10) categories, respectively. 
The third indicator was the time-varying cumulative number of hospitalisations from time of 
entry into the study until an event. The rationale for using only hospitalisations, rather than 
hospitalisations and emergency department visits combined, was that a hospitalisation plausibly 
reflects a greater complication or worsening in a person’s health of greater severity than an 
emergency department visit. This indicator was treated as ordinal, with all cumulative counts 
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greater than the 99th percentile (i.e., 11 hospitalisations) rounded to this value. Therefore, the 
indicator based on the number of hospitalisations since entry in the cohort had twelve categories 
with value ranging from 0-11. 
Table D1. Distribution of the number of hospitalisations and emergency department visits in 
persons 65 years of age and older who were diagnosed with congestive heart failure in Montreal, 
1991-2003.
PercentilesIndicator of health based on hospitalisations 
and emergency department visits Min 25th 50th 75th 95th 99th Max
No. of  hospitalisations and emergency department visits 
in the last 3 months
0 0 1 2 5 8 60
No. of hospitalisations and emergency department visits 
in the last 6 months
0 0 1 2 6 10 63
No. of hospitalisations since beginning of follow-up 0 0 1 2 6 11 111
Indicators of pharmaceutical usage
The fourth indicator was constructed from the pharmaceutical data. Based on expert judgement 
(Dr. James M. Brophy), the indicator relies on the prescribed dose of furosemide (Lasix), which 
is a loop diuretic commonly used in the treatment of heart failure to prevent the body from 
absorbing too much salt and thus relieves congestion. Furosemide is not specific to the treatment 
of congestive heart failure, and may be prescribed to those having liver disease, a kidney disorder 
such as nephrotic syndrome, or to treat hypertension. Typically, furosemide is taken as an oral 
tablet at doses of 20, 40, 80 or 500 mg. Other forms include oral solution and intravenous 
injection, which are generally reserved for in-hospital usage. The indicator was defined 
considering a tablet dosage of 40 mg or less as a “low dose” of furosemide, 41 to 80 mg as a 
“moderate dose” and greater than 80 mg as a “high dose”. Oral solution and intravenous injection 
of furosemide were considered in the latter category (i.e., “high dose”) as they are generally 
administrated to in-patients or out-patients. Those not taking furosemide were considered as a 
separate category. Table D2 describes prescribed usage of furosemide at time of death for persons 
included in the cohort of residents of Montreal, 1991-2003, 65 years of age and older, who were 
diagnosed with congestive heart failure.
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 Table D2. Description of furosemide prescribed usage among persons 65 years of age and older 
who were diagnosed with congestive heart failure and died in Montreal, 1991-2003.
Furosemide (Lasix) usage at time of death Women Men All
Not taking furosemide 6,560 (60%) 4,394 (40%) 10,954
Mild dose (0-40 mg) 8,843 (55%) 7,203 (45%) 16,046 
Moderate dose (41-80 mg) 2,094 (48%) 2,274 (52%) 4,368 
High dose (>80 mg or intravenous or oral solution) 148 (44%) 191 (56%) 339
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Appendix E. Additional Results 
Table E1. Distribution of the indicators of health for all cases and controls included in the nested 
case-control analyses for NO2 (all year).
Furosemide (Lasix) usage Controls Cases
Not taking furosemide 50.9% 34.6%
Mild dose (0-40 mg) 42.7% 50.7%
Moderate dose (41-80 mg) 6.1% 13.8%
High dose (>80 mg or intravenous or oral solution) 0.3% 0.9%
PercentilesIndicator of health based on hospitalisations 
and emergency department visits 1 Min 25th 50th 75th 95th 99th Max
No. of  hospitalisations and emergency department 
visits in the past 3 months
Controls 0 0 1 2 5 8 8
Cases 0 1 2 4 7 8 8
No. of  hospitalisations and emergency department 
visits in the past 6 months
Controls 0 0 1 2 6 10 10
Cases 0 1 3 5 10 10 10
No. of hospitalisations since beginning of follow-up
Controls 0 0 1 2 6 11 11
Cases 0 1 2 4 10 11 11
1The indicators of health based on hospitalisations and emergency department visits were treated as ordinal with all 
cumulative counts greater than the 99th percentile of their marginal distribution rounded to this value (i.e., 8 and 10 
for the indicator based in the number of hospitalisations and emergency department visits in the past three and six 
months, and 11 for the indicator based on the number of hospitalisations since the begging of the follow-up).
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Table E2. Distributions of exposure of the different metrics used for daily 8-hour (9 a.m. to 5 
p.m. from May-September) mean concentrations (ppb) of O3 and daily 24-hour mean 
concentrations (ppb) of NO2, assigned to participants of the case-crossover design, Montreal, 
1991-2003.





deviation Minimum 5th 25th 50th 75th 95th Maximum
8-hour O3 (May-September)
Nearest station 28.7 15.2 0 7.5 17.7 27.2 37.4 57.2 108.8
Inverse-distance 
weighting
29.0 13.2 0.2 10.2 19.6 27.3 36.1 53.7 91.4
Back-
extrapolation 
from a current 
LUR 




30.7 9.3 0 16.9 24.4 30.3 35.9 46.9 83.7
Mean of all 
stations
21.6 10.0 1.1 7.6 14.7 19.8 26.5 39.3 66.6
24-hour NO2 (entire year)
Nearest station 21.5 10.7 0 6.7 13.9 20.3 27.5 40.4 169.5
Inverse-distance 
weighting
21.1 8.1 1.5 8.6 15.4 20.1 25.4 33.9 121.8
Back-
extrapolation 
from a current 
LUR
16.6 7.1 0.7 6.5 11.5 15.5 20.3 28.7 121.5
Mean of all 
stations
20.1 7.8 4.0 5.7 14.6 19.1 24.2 30.0 90.6
Abbreviations: ppb, parts per billion; LUR, land use regression model
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Table E3. Distributions of exposure of the different metrics used for daily 8-hour (9 a.m. to 5 
p.m. from May-September) mean concentrations (ppb) of O3 and daily 24-hour mean 
concentrations (ppb) of NO2, assigned to participants of the nested case-control design, Montreal, 
1991-2003.





deviation Minimum 5th 25th 50th 75th 95th Maximum
8-hour O3 (May-September)
Nearest station 28.9 15.3 0 7.5 17.8 27.3 37.5 57.5 108.8
Inverse- distance 
weighting
29.2 13.3 0.1 10.3 19.7 27.5 36.4 54.2 91.4
Back-
extrapolation 
from a current 
LUR 




30.8 9.4 0 16.8 24.4 30.3 36.0 47.2 83.7
24-hour NO2 (entire year)
Nearest station 21.6 10.9 0 6.7 14.0 20.4 27.7 40.9 169.5
Inverse-distance 
weighting
21.2 8.2 1.5 8.7 15.4 20.2 25.5 34.2 138.6
Back-
extrapolation 
from a current 
LUR
16.6 7.2 0.7 6.5 11.5 15.4 20.3 28.9 131.5
Abbreviations: ppb, parts per billion; LUR, land use regression model
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Table E4. Distribution of selected weather variables for all years and summers (May-September, 
inclusive), 1991-2003, Montreal, Canada
Environmental variables Percentiles 
Mean
Standard 
deviation Minimum 25th 50th 75th Maximum
All year
Daily Temperature (ºC)
Mean 7.2 11.7 -27.6 -1.5 7.9 17.7 29.2
Minimum 2.7 11.5 -31.2 -5.1 3.2 12.6 25.8
Maximum 11.3 12.2 -24.0 1.6 12.0 22.2 35.4
Average relative humidity 
(%) 70.2 12.4 28.54 61.8 70.5 79.3 100
May-September
Daily Temperature (ºC)
Mean 18.1 4.6 3.3 15.2 18.7 21.4 29.2
Minimum 13.2 4.9 -1.2 10.0 13.7 16.7 25.8
Maximum 22.7 5.0 4.9 19.5 23.3 26.3 35.4
Average relative humidity 
(%) 68.7 11.7 28.5 60.9 69.0 76.9 97.8
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Table E5: Spearman correlation coefficients of same-day daily mean concentrations of air pollutants for the different metrics, and mean values of 























station 0.10 -0.02 1
IDW 0.18 -0.01 0.79 1
Back-





stations 0.18 -0.01 0.63 0.94 0.83 1
Nearest 
station 0.51 -0.38 -0.12 0.09 0.07 0.18 1
IDW 0.61 -0.43 0.08 0.20 0.17 0.24 0.89 1
BME 0.59 -0.37 0.11 0.22 0.19 0.24 0.73 0.85 1
Back-




stations 0.49 -0.32 0.03 0.08 0.08 0.07 0.71 0.84 0.81 0.62 1
1 Spearman correlation coefficients for O3 were computed using data limited to the period of May-September, inclusively. Abbreviations: O3, ozone; NO2, 
nitrogen dioxide; IDW, inverse-distance weighting; back-extrapol., back-extrapolation from a land use regression surface; BME, Bayesian maximum entropy 
model.
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Table E6. Model fit of the adjusted cumulative response functions for air pollutants fitted using 
linear and non-linear structures in the case-crossover analyses over lags 0 to 3 days for the odds 
of non-accidental mortality among subjects 65 years of age and over with congestive heart 
failure, Montreal, 1991-2003.
Metric of exposure Akaike information criterion (AIC)












Linear 93,152 33,791 286,209 104,725
Natural cubic splines, 2df 93,159 33,794 286,212 104,727
Natural cubic splines, 3df 93,161 33,799 296,216 104,727
Inverse-distance 
weighting
Linear 93,151 33,790 286,218 104,727
Natural cubic splines, 2df 93,157 33,795 286,222 104,727
Natural cubic splines, 3df 93,161 33,803 286,227 106,733
Back-extrapolation from 
LUR
Linear 92,640 33,791 284,623 104,723
Natural cubic splines, 2df 92,647 33,796 284,628 104,727
Natural cubic splines, 3df 92,652 33,803 284,633 104,731
Bayesian maximum 
entropy model
Linear N/A 33,789 N/A 104,735
Natural cubic splines, 2df N/A 33,796 N/A 104,742
Natural cubic splines, 3df N/A 33,798 N/A 104,747
Mean of all stations
Linear 93,153 33,793 N/A N/A
Natural cubic splines, 2df 93,159 33,794 N/A N/A
Natural cubic splines, 3df 93,162 33,799 N/A N/A
Abbreviations: df, degrees of freedom, LUR, land use regression model, N/A, not available (the Bayesian maximum 
entropy model for NO2 was not developed and the nested case-control analysis requires variation in the daily 
exposure across individuals; thus cannot be performed using the mean of all stations).
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Table E7. Estimated percentage change in non-accidental mortality among subjects 65 years of 
age and over with congestive heart failure according to an interquartile range increase in the daily 
24-hour mean concentrations (ppb) of NO2 (all year) and the daily 8-hour mean concentrations 
(ppb) of O3 (May-September), Montreal, 1991–2003.1 
Lagged effect NO2 - % Change (95% CI) O3 - % Change (95% CI)












Lag 0 -2.5 (-5.8, 0.8) -0.4 (-2.8, 2.1) 7.7 (0.3, 15.7) 1.6 (-3.2, 6.7) 1.8 (-1.7, 5.3)
Lag 1 -1.0 (-4.7, 2.9) 1.7 (-1.0, 4.6) -6.0 (-13.0, 1.6) -1.8 (-6.7, 3.3) 2.1 (-1.6, 6.0)
Lag 2 -0.2 (-4.0, 3.7) 2.4 (-0.4, 5.3) -1.0 (-8.5, 7.1) -1.4 (-6.3, 3.8) 0.3 (-3.5, 4.1)
Lag 3 -1.9 (-5.2, 1.5) -1.6 (-3.9, 0.8) 6.4 (-0.9, 14.3) -0.6 (-5.4, 4.4) 0.1 (-3.4, 3.6)
Cumulative -5.5 (-8.1, -2.9) 2.1 (-1.1, 5.5) 6.7 (0.3, 13.5) -2.2 (-9.2, 5.2) 4.3 (-0.5, 9.2)
Inverse-distance 
weighting
Lag 0 -4.8 (-12.6, 3.6) 0.1 (-2.3, 2.5) 34.2 (6.8, 68.6) 1.2 (-3.5, 6.3) 1.2 (-1.9, 4.4)
Lag 1 -0.1 (-9.1, 9.8) 1.6 (-1.1, 4.3) -11.9 (-31.2, 12.7) 2.6 (-2.4, 7.8) 3.9 (0.4, 7.4)
Lag 2 1.2 (-8.0, 11.4) 2.6 (-0.1, 5.4) -10.6 (-30.3, 14.6) 0.9 (-4.1, 6.1) 1.0 (-2.4, 4.6)
Lag 3 -5.5 (-13.2, 2.9) -1.4 (-3.7, 0.8) 12.2 (-10.7, 40.8) -2.3 (-7.0, 2.6) -0.7 (-3.8, 2.5)
Cumulative -9.0 (-15.2, -2.4) 2.8 (-0.3, 6.1) 18.5 (-2.6, 44.1) 2.4 (-4.9, 10.3) 5.4 (1.2, 9.8)
Back-extrapolation 
from LUR
Lag 0 0.4 (-6.6, 7.9) 0.3 (-2.2, 2.8) 3.6 (-4.8, 12.7) 1.6 (-3.8, 7.3) 1.8 (-2.1, 5.8)
Lag 1 2.2 (-6.0, 11.2) 1.7 (-1.1, 4.6) -3.0 (-12.0, 7.0) -0.4 (-5.9, 5.5) 3.1 (-1.2, 7.6)
Lag 2 1.9 (-6.4, 10.9) 2.6 (-0.2, 5.6) -1.0 (-10.4, 9.4) 1.6 (-4.2, 7.7) 1.5 (-2.8, 6.0)
Lag 3 -1.6 (-8.5, 5.9) -1.5 (-3.9, 0.9) 7.8 (-1.0, 17.4) 0.6 (-4.9, 6.4) 0.5 (-3.4, 4.6)
Cumulative 2.9 (-0.9, 6.9) 3.0 (-0.4, 6.6) 7.3 (3.0, 11.9) 3.5 (-4.5, 12.1) 7.1 (1.7, 12.7)
Bayesian maximum 
entropy model
Lag 0 N/A N/A 0.6 (-6.1, 7.9) -0.9 (-5.9, 4.4) 0.9 (-2.6, 4.5)
Lag 1 N/A N/A -0.1 (-7.1, 7.5) 2.8 (-2.6, 8.5) 4.7 (0.6, 8.9)
Lag 2 N/A N/A 1.0 (-6.2, 8.7) -2.1 (-7.3, 3.3) -0.3 (-4.3, 3.8)
Lag 3 N/A N/A -0.8 (-7.5, 6.4) -2.7 (-7.6, 2.4) -1.2 (-4.6, 2.3)
Cumulative N/A N/A 0.8 (-7.3, 9.5) -3.0 (-10.0, 4.5) 4.0 (-0.1, 8.3)
Mean of all stations
Lag 0 N/A 0.1 (-2.2, 2.5) N/A 0.8 (-3.4, 5.2) 2.0 (-1.2, 5.4)
Lag 1 N/A 1.4 (-1.2, 4.1) N/A 2.2 (-2.5, 7.1) 3.4 (-0.4, 7.4)
Lag 2 N/A 2.2 (-0.5, 5.0) N/A -0.6 (-5.1, 4.2) 0.2 (-3.6, 4.1)
Lag 3 N/A -1.4 (-3.6, 0.9) N/A -2.2 (-6.3, 2.0) -1.4 (-4.6, 1.9)
Cumulative N/A 2.3 (-0.8, 5.6) N/A 0.1 (-5.7, 6.3) 4.3 (0.3, 8.5)
Abbreviations: LUR, land use regression, N/A, not applicable (the Bayesian maximum entropy model for NO2 was 
not developed and the nested case-control analysis requires variation in the daily exposure across individuals; thus 
cannot be performed using the mean of all stations). 
1For NO2, interquartile ranges (IQRs) were 13.6, 10.0, 8.8 and 9.6 ppb for the nearest station approach, inverse-
distance weighting, back-extrapolation from a land use regression (LUR), and the daily mean across all stations 
(“Mean of stations”), respectively. For O3, IQRs were 19.6, 16.6, 16.4, 11.6 and 11.8 ppb for nearest station 
approach, inverse-distance weighting, back-extrapolation from a land use regression (LUR), Bayesian maximum 
entropy model and the daily mean across all stations, respectively.
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Table E8. Effect of adjustments for weather (maximum temperature and relative humidity) in the 
case-crossover analyses on the odds of non-accidental mortality among subjects 65 years of age 






AIC % Change (95%CI) AIC % Change  (95%CI)
Nearest station
Unadjusted for weather 93338 2.9 (-0.2, 6.1) 33797 4.3 (-0.5, 9.2)
Adjusted for weather 93152 2.1 (-1.1, 5.5) 33791 -2.2 (-9.2, 5.2)
Inverse-distance weighting
Unadjusted for weather 93335 3.5 (0.5, 6.6) 33790 5.4 (1.2, 9.8)
Adjusted for weather 93151 2.8 (-0.3, 6.1) 33790 2.4 (-4.9, 10.3)
LUR back-extrapolated
Unadjusted for weather 92823 3.7 (0.5, 7.0) 33793 7.1 (1.7, 12.7)
Adjusted for weather 92640 3.0 (-0.4, 6.6) 33791 3.5 (-4.5, 12.1)
Bayesian maximum entropy
Unadjusted for weather N/A N/A 33792 4.0 (-0.1, 8.3)
Adjusted for weather N/A N/A 33789 -3.0 (-10.0, 4.5)
Mean of all stations
Unadjusted for weather 93338 3.1 (0.1, 6.1) 33790 4.3 (0.3, 8.5)
Adjusted for weather 93153 2.3 (-0.8, 5.6) 33789 0.1 (-5.7, 6.3)
Abbreviations: LUR, land use regression, N/A, not applicable
1 Effect estimates are from the case-crossover analysis that controlled for time invariant factors and temporal trend 
by design. The model adjusted for weather included maximum temperature (natural cubic spline with 3 df), and 
relative humidity (linear), from a distributed lag non-linear model using an unconstrained lag structure over lags 0 to 
3 days. For NO2, interquartile ranges (IQRs) were 13.6, 10.0, 8.8 and 9.6 ppb for the nearest station, inverse-distance 
weighting, LUR back-extrapolated and the daily mean of all stations, respectively. For O3, IQRs were 19.6, 16.6, 
16.4, 11.6 and 11.8 ppb for the nearest station, inverse-distance weighting, LUR back-extrapolated, Bayesian 
maximum entropy and the daily mean of all stations, respectively.
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Table E9. Effects of adjustments for the indicators of health in the nested case-control analyses 
on the hazards of non-accidental mortality among subjects 65 years of age and over with 





AIC % Change (95% CI) AIC % Change (95% CI)
Nearest station 
Model without any indicator of health 286,209 -5.5 (-8.1, -2.9) 104,726 6.7 (0.3, 13.5)
Model adjusting for Hosp + ER in past 3 months 266,811 -4.8 (-7.4, -2.1) 97,362 3.9 (-2.3, 10.5)
Model adjusting for Hosp + ER in past 6 months 267,138 -5.5 (-7.7, -2.5) 97,211 4.0 (-2.2, 10.6)
Model adjusting for Hosp over whole follow-up 267,764 -7.3 (-9.8, -4.7) 97,656 10.5 (3.8, 17.5)
Model adjusting for furosemide 281,502 -5,2 (-7.8, -2.5) 102,792 5.9 (-0.5, 12.6)
Inverse-distance weighting
Model without any indicator of health 286,218 -9.0 (-15.2, -2.4) 104,727 18.5 (-2.6, 44.1)
Model adjusting for Hosp + ER in past 3 months 266,814 -9.5 (-15.7, -2.9) 97,361 17.1 (-3.9, 42.6)
Model adjusting for Hosp + ER in past 6 months 267,141 -10.7 (-16.8, -4.2) 97,210 19.2 (-2.1, 45.2)
Model adjusting for Hosp over whole follow-up 267,767 -16.4 (-22.1, -10.3) 97,652 45.6 (19.6, 77.2)
Model adjusting for furosemide 281,511 -8.1 (-14.4, -1.4) 102,791 15.7 (-5.0, 40.8)
LUR back-extrapolated
Model without any indicator of health 284,623 2.9 (-0.9, 6.9) 104,723 7.3 (3.0, 11.9)
Model adjusting for Hosp + ER in past 3 months 265,347 1.7 (-2.2, 5.6) 97,361 5.6 (1.3, 10.1)
Model adjusting for Hosp + ER in past 6 months 265,672 1.0 (-2.8, 4.9) 97,209 6.1 (1.8, 10.6)
Model adjusting for Hosp over whole follow-up 266,279 -0.6 (-4.3, 3.3) 97,641 12.2 (7.6, 17.0)
Model adjusting for furosemide 279,918 2.0 (-1.8, 5.9) 102,789 6.7 (2.3, 11.2)
Bayesian maximum entropy
Model without any indicator of health N/A N/A 104,736 0.8 (-7.3, 9.5)
Model adjusting for Hosp + ER in past 3 months N/A N/A 97,370 -0.6 (-8.6, 8.1)
Model adjusting for Hosp + ER in past 6 months N/A N/A 97,219 -0.2 (-8.2, 8.6)
Model adjusting for Hosp over whole follow-up N/A N/A 97,672 1.7 (-6.5, 10.6)
Model adjusting for furosemide N/A N/A 102,800 0.8 (-7.3, 9.6)
Abbreviations: AIC, Akaike information criterion; ER, emergency room visits; Hosp, hospitalisation; LUR, land use 
regression; N/A, not applicable.
1 Effect estimates are from the nested case-control analysis that controlled for temporal factor and gender by design. 
The model adjusted for weather included maximum temperature (natural cubic spline with 3 df), and relative 
humidity (linear), from a distributed lag non-linear model using an unconstrained lag structure over lags 0 to 3 days. 
For NO2, interquartile ranges (IQRs) were 13.6, 10.0 and 8.8 ppb for the nearest station, inverse-distance weighting 
and LUR back-extrapolated methods, respectively. For O3, IQRs were 19.6, 16.6, 16.4 and 11.6 ppb for the nearest 
station, inverse-distance weighting, LUR back-extrapolated and Bayesian maximum entropy methods, respectively.
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Table E10. Cumulative percentage change (and 95% confidence interval) in non-accidental 
mortality among subjects 65 years of age and over with congestive heart failure according to an 
interquartile range increase in the daily 24-hour mean concentrations (ppb) of NO2 for all year 
and the warm season (May-September), Montreal, 1991–2003.
% Change (95% CI)
Case-crossover Nested case-control
All year May-September All year  May-September
Nearest station 2.1 (-1.1, 5.5) 1.3 (-4.0, 6.9) -5.5 (-8.1, -2.9) -5.2 (-8.8, -1.5)
Inverse-distance 
weighting
2.8 (-0.3, 6.1) 1.3 (-4.1, 6.9) -9.0 (-15.2, -2.4) -9.4 (-17.7, -0.3)
LUR back-
extrapolated
3.0 (-0.4, 6.6) 1.6 (-4.1, 7.7) 2.9 (-0.9, 6.9) -0.2 (-5.8, 5.8)
Mean of stations 2.3 (-0.8, 5.6) -0.7 (-5.9, 4.9) N/A N/A
Abbreviations: N/A, not applicable; LUR, land use regression.
1 For the case-crossover, the results are from the model adjusting for weather. For all year, interquartile ranges were 
13.6, 10.0, 8.8 and 9.6 ppb for the nearest station approach, inverse-distance weighting, LUR back-extrapolated, and 
the daily mean across all stations (“Mean of stations”), respectively. For the warm season, interquartile ranges were 
12.7, 8.5, 7.3, 7.8 ppb for the nearest station approach, inverse-distance weighting, LUR back-extrapolated, and the 
daily mean across all stations (“Mean of stations”), respectively.
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Table E11. Cumulative percent change (and 95% confidence interval) in the case-crossover 
analyses on the odds of non-accidental mortality among subjects 65 years of age and over with 
congestive heart failure per interquartile range increase in air pollutant, Montreal, 1991–2003, 
according to level of agreement in the exposure assigned to postal areas by the different metrics.1
% Change (95% CI)









Postal districts of higher agreement 3.1 (-1.6, 8.0) -3.7 (-12.4, 5.9) 2.2 (-3.7, 8.5)
Postal districts of lower agreement 1.1 (-3.3, 5.7) -0.2 (-11.1, 12.2) 7.6 (-0.1, 15.9)
Inverse-distance weighting
Postal districts of higher agreement 3.8 (-0.5, 8.3) 0.4 (-8.9, 10.6) 3.5 (-2.0, 9.2)
Postal districts of lower agreement 1.6 (-3.0, 6.4) 5.2 (-6.3, 18.2) 8.4 (1.7, 15.6)
LUR back-extrapolated
Postal districts of higher agreement 3.4 (-1.0, 7.9) 2.6 (-7.4, 13.7) 4.6 (-1.5, 11.1)
Postal districts of lower agreement 2.9 (-2.6, 8.7) 8.7 (-5.7, 25.3) 14.4 (-0.4, 13.2)
Mean of all stations
Postal districts of higher agreement 3.1 (-1.2, 7.5) -2.0 (-9.5, 6.0) 2.5 (-2.7, 7.9)
Postal districts of lower agreement 1.3 (-3.4, 6.1) 2.7 (-46.3, 12.5) 6.8 (0.6, 13.3)
Bayesian maximum entropy
Postal districts of higher agreement N/A -3.2 (-12.0, 6.5) 2.6 (-2.7, 8.1)
Postal districts of lower agreement N/A -2.7 (-13.7, 9.8) 6.2 (-0.4, 13.2)
Abbreviations: N/A, not applicable; LUR, land use regression.
1 Effect estimates for NO2 are from the case-crossover that controlled for time invariant factors and temporal trend by 
design and we statistically adjusted for maximum temperature (natural cubic spline with 3 df), and relative humidity 
(linear), from a distributed lag non-linear model accumulated over lags 0 to 3 days. For O3 we presented the results 
adjusting (“Adjusted for weather”) and unadjusting for weather (“Unadjusted for weather”) as we were concerned 
with possible overadjustment. Threshold value used to distinguish postal districts of higher agreement from lower 
agreement was the median of the mean intraclass correlation coefficient (ICC) across pairs of methods by postal code 
area (ICC=0.75 for NO2, ICC = 0.65 for O3). For NO2, there were 17,389 cases in postal code districts of higher 
agreement and 14,152 cases in postal districts of lower agreement. For O3 there were 6,751 and 5,061 cases that were 
residents of postal district of higher and lower agreement, respectively. For NO2, interquartile ranges (IQRs) were 
13.6, 10.0, 8.8, 9.6 ppb for the nearest station, inverse-distance weighting, LUR back-extrapolated and mean of all 
stations, respectively. For O3, IQRs were 19.6, 16.6, 16.4, 11.8, 11.6 ppb for the nearest station, inverse-distance 
weighting, LUR back-extrapolated, mean of all stations and Bayesian maximum entropy, respectively. 
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Figure E1. Adjusted cumulative response functions fitted as natural cubic splines with 3 degrees 
of freedom in the case-crossover analyses over lags 0 to 3 days between the odds of non-
accidental mortality among subjects 65 years of age and over with congestive heart failure in 
Montreal, 1991-2003, and the spatially-resolved daily 24-hour mean exposures to ambient NO2 
predicted from the following methods: (A) nearest station; (B) inverse-distance weighting 
(“IDW”); (C) back-extrapolation from a land use regression model (“LUR-back-extrapolated”); 
(D) mean of all stations. We statistically adjusted for maximum temperature (natural cubic splines 
with 3 df), and relative humidity (linear), from a distributed lag non-linear model accumulated over 
lags 0 to 3 days. An unconstrained lag structure was always used. The odds ratios (OR) are relative to 
the minimum value of the exposure distribution. The solid line in blue represents the mean OR from 
the non-linear function fitted using natural cubic splines with 3 df, with shaded grey representing the 
95% confidence interval. The rug plot over the horizontal axis shows the distribution of NO2 




Figure E2. Adjusted cumulative response functions fitted as natural cubic splines with 3 degrees of 
freedom in the case-crossover analyses over lags 0 to 3 days between the odds of non-accidental 
mortality among subjects 65 years of age and over with congestive heart failure in Montreal, 1991-
2003, and the spatially-resolved daily mean 8-hour exposures to ambient O3 predicted from the 
following methods: (A) nearest station; (B) inverse-distance weighting (“IDW”); (C) back-
extrapolation from a land use regression model (“LUR-back-extrapolated”); (D) combined LUR 
and Bayesian maximum entropy model (“BME”); (E) mean of all stations. We statistically adjusted 
for maximum temperature (natural cubic splines with 3 df), and relative humidity (linear), from a 
distributed lag non-linear model accumulated over lags 0 to 3 days. An unconstrained lag structure was 
always used. The odds ratios (OR) are relative to the minimum value of the exposure distribution. The 
solid line in blue represents the mean OR from the non-linear function fitted using natural cubic splines 
with 3 df, with shaded grey representing the 95% confidence interval. The rug plot over the horizontal axis 
shows the distribution of O3 exposures of cases and controls, whereas the vertical line (dotted) indicates 
the 95th percentile. 
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Figure E3. Adjusted cumulative response functions fitted as natural cubic spline with 3 degrees 
of freedom in the nested case-control analyses over lags 0 to 3 days between the hazards of non-
accidental mortality among subjects 65 years of age and over with congestive heart failure in 
Montreal, 1991-2003, and the spatially-resolved daily 24-hour mean exposures to ambient NO2 
predicted from the following methods: A) nearest station; B) inverse-distance weighting 
(“IDW”); C) back-extrapolation from a land use regression model (“LUR-back-extrapolated”). 
An unconstrained lag structure was always used. The hazard ratios (HR) are relative to the minimum 
value of the exposure distribution. The solid line in blue represents the mean HR from the non-linear 
function fitted using natural cubic splines with 3 degrees of freedom, with shaded grey representing 
the 95% confidence interval. The rug plot over the horizontal axis shows the distribution of NO2 
exposures of cases and controls, whereas the vertical line (dotted) indicates the 95th percentile.
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Figure E4. Adjusted cumulative response functions fitted as natural cubic spline with 3 degrees of 
freedom in the nested case-control analyses over lags 0 to 3 days between the hazards of non-
accidental mortality among subjects 65 years of age and over with congestive heart failure in 
Montreal, 1991-2003, and the spatially-resolved daily 8-hour mean exposures to ambient O3 
predicted from the following methods: A) nearest station; B) inverse-distance weighting (“IDW”); 
C) back-extrapolation from a land use regression model (“LUR-back-extrapolated”); D) combined 
LUR and Bayesian maximum entropy model (“BME”). An unconstrained lag structure was always 
used. The hazard ratios (HR) are relative to the minimum value of the exposure distribution. The solid line 
in blue represents the mean HR from the non-linear function fitted using natural cubic splines with 3 
degrees of freedom, with shaded grey representing the 95% confidence interval. The solid and dashed 
lines in green represent the mean HR and the 95% confidence interval of linear response function, 
respectively. The rug plot over the horizontal axis shows the distribution of O3 exposures of cases and 
controls, whereas the vertical line (dotted) indicates the 95th percentile. 
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Figure E5. Unadjusted cumulative response function for maximum temperature and relative 
humidity in the case-crossover analyses over lags 0 to 3 days for the odds of non-accidental 
mortality among subjects 65 years of age and over with congestive heart failure, all year and the 
warm season (May-September), Montreal, 1991-2003. Daily maximum temperature and relative 
humidity were fitted from a distributed lag non-linear model over lag 0-3 day using natural cubic splines 
with 3 df and a linear function, respectively, and always using an unconstrained lag structure. The odds 
ratios (OR) and 95% confidence intervals are relative to A) 10°C, B) 23°C, C) 68%, D) 70%, which 
corresponded to the mean value of the weather variables over the different time periods. 
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Response functions for weather variables included in the case-crossover analyses and for 
contextual variables included in the nested case-control analyses.
 
Figure E5 shows below the unadjusted cumulative response function for maximum temperature 
and relative humidity in the case-crossover analyses over lags 0 to 3 days for the odds of non-
accidental mortality among subjects 65 years of age and over with congestive heart failure, all 
year and the warm season (May-September), Montreal, 1991-2003. The odds of non-accidental 
showed a strong increase at higher maximum temperatures, starting at about 20°C, whereas when 
limited to the warm season the response function was “U”-shaped with the lowest risk at about 
20°C. Relative humidity was positively associated with the odds of mortality, and the response-
function was consistent with linearity for the entire year and in the warm season.
Figure E6 shows below the unadjusted cumulative response functions in the nested case-control 
analyses of the hazards of non-accidental mortality among subjects 65 years of age and over with 
congestive heart failure, Montreal, 1991-2003, for age and selected area-based contextual 
covariates. For age and unemployment the mortality response-functions were positive and 
monotonically increasing. For the percentage of adults who did not complete high school the 
relationship was positive and linear, whereas the risk of mortality decreased with increasing 
median household income until approximately the 97th percentile (approximately $Cdn60,000), 
above which daily mortality appears to increase but the confidence interval was wide.
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Figure E6. Unadjusted cumulative response functions in the nested case-control analyses of the 
hazards of non-accidental mortality among subjects 65 years of age and over with congestive heart 
failure, Montreal, 1991-2003, for: (A) age and the following time-varying area-based contextual 
covariates: (B) unemployment rate; (C) percentage of adults that did not complete high school; D) 
median household income. All response-functions were fitted using natural cubic splines with 3df, and 




Figure E7. Unadjusted cumulative response functions in the nested case-control analyses of the 
hazards of non-accidental mortality among subjects 65 years of age and over with congestive heart 
failure, Montreal, 1991-2003, for: A) number of hospitalisations (hosp) and emergency room visits 
(ER) in the last 3 months; B) number of hospitalisation and emergency visits in the last 6 months; C) 
number of hospitalisations during the whole follow-up; D) furosemide (Lasix) usage. The hazard 
ratios (HR) and 95% confidence intervals were expressed relative to a value of zero for each variable 
(vertical line). For the indicator based on the prescribed dose of furosemide, the HR for the different 
categories of dose (low, moderate and high) are relative to those not taking furosemide. 
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Results of the assessment of effect modification according to the indicators of “declining 
health” based on the number of hospitalisations and emergency room in the past three and 
six months, and the cumulative number of hospitalisations since entry in the cohort
Figure E8, E9 and E10 shows below the results of the assessment of effect modification 
according to the indicators based on the number of hospitalisations and emergency room in the 
past three and six months, and the cumulative number of hospitalisations since entry in the 
cohort, respectively. 
For NO2, in the case-crossover the mean percentage change in the cumulative risk of non-
accidental mortality showed a increasing trend according to the number of hospitalisations and 
emergency department visits in the past three months, whereas in the case-control there was an 
increasing trend. However, for both designs the confidence intervals were wide, particularly for 
the higher values of the indicators, and there was substantial overlap in the confidence intervals 
across the selected values of the indicator.
For O3, in the nested case-control analysis for the nearest station and back-extrapolation methods 
from the LUR showed an increasing trend in the mean estimated effect according to the number 
of hospitalisations and emergency department visits in the past three (Figure E8) and six months 
(Figure E9). However, the confidence intervals were wide and overlapped between the different 
values of the indicator. Similarly, in the case-crossover analyses, the risk of non-accidental 
mortality increased with the number of hospitalisations and emergency department visits only for 
the back-extrapolation from the LUR, but the confidence intervals were wide and overlapped.
In Figure E10, for NO2 there was a decreasing trend in non-accidental mortality according to the 
number of hospitalisations for both designs, but the decreasing trend was more modest in the 
case-crossover and there was substantial overlap in the confidence intervals. For O3, the number 
of hospitalisations in the nested case-control analysis had practically no influence on the 
associations, whereas in the case-crossover analyses the odds of non-accidental mortality 




Figure E8. Estimated cumulative percentage change in non-accidental daily mortality over lag 0-3 
day per interquartile range increase in (A) daily 24-hour mean exposures to ambient NO2 (all year) 
and, (B) daily 8-hour mean exposures to ambient O3 (May-September), according to the number of 
hospitalisations and emergency room visits in the past three months. For O3, we present results for the 
case-crossover adjusting (“Adj. Case-crossover”) and not adjusting for weather (“Unadj. Case-
crossover”). Numbers on the horizontal axis are selected values of hospitalisation and emergency room 
visits, whereas “No EMM” represents the model without including the number of hospitalisations and 
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emergency room visits. Dots represent maximum likelihood estimates and bars represent 95% confidence 
intervals. We could not in the nested case-control analyses estimate the mean of all stations, as this metric 
does not have any variability between individuals. For NO2, interquartile ranges (IQRs) were 13.6, 10.0, 
8.8 and 9.6 ppb for the nearest station approach (“Nearest station”), inverse-distance weighting (“IDW”), 
back-extrapolation from a land use regression (“LUR back-extrapol.”), and the daily mean across all 
stations (“Mean of stations”), respectively. For O3, IQRs were 19.6, 16.6, 16.4, 11.6 and 11.8 ppb for the 




Figure E9. Estimated cumulative percentage change, over lag 0-3 day, in non-accidental daily 
mortality per interquartile range increase in (A) daily mean 24-hour mean exposures to ambient 
NO2 (all year) and, (B) daily 8-hour mean exposures to ambient O3 (May-September), according to 
the number of hospitalisations and emergency room visits in the past six months. Dots represent 
maximum likelihood estimates and bars represent 95% confidence intervals. Numbers on the horizontal 
axis are selected values of hospitalisation and emergency room visits, whereas “No EMM” represents the 
model without including the number of hospitalisations and emergency room visits. For O3, we present the 
results from the case-crossover adjusting (“Adj. Case-crossover”) and unadjusting for weather (“Unadj. 
Case-crossover”) as we were concerned with possible overadjustment. For both air pollutants the nested 
case-control analysis could not be performed using the mean of all stations, as it requires some variability 
in the exposure between individuals.  For NO2, interquartile ranges (IQRs) were 13.6, 10.0, 8.8 and 9.6 
ppb for the measurement at the nearest station (“Nearest station”), inverse-distance weighting 
interpolation (“IDW”), back-extrapolation from a land use regression (“LUR back-extrapol.”), and the 
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daily mean across all stations (“Mean of stations”), respectively. For O3, IQRs were 19.6, 16.6, 16.4, 11.6 




















































Figure E10. Estimated cumulative percentage change in non-accidental daily mortality over lag 0-3 
day per interquartile range increase in (A) daily 24-hour mean exposures to ambient NO2 (all year) 
and, (B) daily 8-hour mean exposures to ambient O3 (May-September), according to the number of 
hospitalisations since the beginning of the follow-up. For O3, we present results for the case-crossover 
adjusting (“Adj. Case-crossover”) and not adjusting for weather (“Unadj. Case-crossover”). Numbers on 
the horizontal axis are specific values of hospitalisation, whereas “No EMM” represents the model 
without including the number of hospitalisations. Dots represent maximum likelihood estimates and bars 
represent 95% confidence intervals. We could not in the nested case-control analyses estimate the mean of 
all stations, as this metric does not have any variability between individuals. For NO2, interquartile ranges 
(IQRs) were 13.6, 10.0, 8.8 and 9.6 ppb for the nearest station approach (“Nearest station”), inverse-
distance weighting (“IDW”), back-extrapolation from a land use regression (“LUR back-extrapol.”), and 
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the daily mean across all stations (“Mean of stations”), respectively. For O3, IQRs were 19.6, 16.6, 16.4, 





Figure E11. Estimated cumulative percentage change, over lag 0-3 day, in non-accidental daily 
mortality per interquartile range increase in (A) daily mean 24-hour mean exposures to ambient 
NO2 (all year) and, (B) daily 8-hour mean exposures to ambient O3 (May-September), by gender. 
For O3, we present results for the case-crossover adjusting (“Adj. Case-crossover”) and not adjusting for 
weather (“Unadj. Case-crossover”). Numbers on the horizontal axis denote single day lags (0 to 3) and the 
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cumulative for these lags (“cumul.”). Dots represent maximum likelihood estimates and bars represent 
95% confidence intervals. We could not in the nested case-control analyses estimate the mean of all 
stations, as this metric does not have any variability between individuals. For NO2, interquartile ranges 
(IQRs) were 13.6, 10.0, 8.8 and 9.6 ppb for the nearest station approach (“Nearest station”), inverse-
distance weighting (“IDW”), back-extrapolation from a land use regression (“LUR back-extrapol.”), and 
the daily mean across all stations (“Mean of stations”), respectively. For O3, IQRs were 19.6, 16.6, 16.4, 
11.6 and 11.8 ppb for the nearest station, IDW, LUR back-extrapolated, BME and mean of stations, 
respectively.
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Appendix F. Example of R code
We performed our analyses in R, version 3.3.3 (R Foundation for Statistical Computing, 2016).  
For both type of analyses, i.e., time-stratified case-crossover and nested case-control, we used the 
Cox proportional hazards model for time-dependent variables (survival package, version 2.41-3) 
and we incorporated distributed lag non-linear models to simultaneously consider potential non-
linear and delayed dependencies in the association between daily mortality and air pollution, 
accounting for possible non-linear effects of air pollution and other covariates (temperature and 
relative humidity) (dlnm package, version 2.3.2). 
Traditionally, for both types of analyses the strata option is used in the code to specify that the 
models need to account for the matched nature of the selection of cases and controls. Rather than 
using this method we accounted for the matched nature of the selection of cases and controls by 
defining time intervals that were specific to each risk set and not overlapping. This method led to 
computational times that were approximately 300 times faster than the traditional approach. 
Below we show an example of the code used in R (see Stage 1) for this approach within the 
context of the nested case-control analysis between NO2 and mortality. For simplicity we show 
an unadjusted model. Note that the exact same procedure and code can be used for a case-
crossover analysis if time variables are defined according to each subject identification number.
Using the indicator based on the number of hospitalisations during the follow-up and the 
indicator based on furosemide (Lasix) usage as examples, we present in the second and third 
stage of the R code the procedure used to investigate potential effect modification in the 
associations between air pollution and mortality according to an ordinal and a categorical 
variable, respectively. Briefly, for the ordinal indicator of health and the cross-basis function for 
the air pollutant the procedure consisted into adding in the regression models an interaction term 
between the indicator of health and the cross-basis function for the air pollutant (Gasparrini et al., 
2015; Gasparrini et al., 2016). The interaction term was centered at selected values of the 
indicator for which we computed estimates of association and their 95% confidence intervals for 
an interquartile increment in air pollutant. As for categorical variables, the DLNM can handle 
interaction only for binary variables, not for a multi-level categorical variable. Therefore for the 
indicator based on furosemide usage, which is a four-level categorical variable, we used a 
dummy parameterization to represent each category. An interaction term was created for each 
binary indicator and the cross-basis for air pollutant, centered accordingly to the selected values 
of the indicator for which we wanted to report the estimate of associations. All interaction terms 
were then included in the Cox regression model.
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Example of R code: 
#################################################################################################
# STAGE 1: EXAMPLE OF CODE FOR THE NESTED CASE-CONTROL BETWEEN AMBIENT NO2 AND MORTALITY  #
# INCPORATING DISTRIBUTED LAG NON-LINEAR MODELS FOR AIR POLLUTANT #
#################################################################################################
library(survival) ; library(dlnm)
#STEP 1: LOADING THE DATASET.
# This is the Dataset for the nested case-control analysis.
no2data<-read.table(file="NESTEDCC_NO2.csv", sep=",", header=TRUE)
head(no2data)
#STEP 2: DEFINE MATRIX OF EXPOSURE FOR NO2
# I am considering a lag period of 4 days, (i.e.,lag 0 (same-day) to lag 3-day)
#MATRIX FOR NO2
QNO2near <- as.matrix (no2data[,(6:9)])
colnames(QNO2near) <- paste("nearlag", 0:3, sep="")
QNO2near [1:3, 1:4]
#STEP 3: DEFINE CROSSBASIS FOR NO2, AND WEATHER VARIABLES
#CROSS-BASIS FOR NO2 (using concentrations from the nearest station)
# The selected function is linear with an unconstrained lag structure.
basisrefno2near<-crossbasis(QNO2near, lag=3, argvar=list(fun="lin"), arglag=list(fun="integer"))
#STEP 5: COX REGRESSION MODEL
# I am using cox regression, which is equivalent to conditional logistic. 
# The variables included in the models are defined as following:
# cc, case/control status (1=case; 0=control);
# riskset_id, risk set identification number (defined as integer);
# basisrefno2near, cross-basis for NO2;
# DEFINE TIME VARIABLES IN A WAY THAT RISK SETS ARE AUTOMATICALLY DEFINED
# (NO STRATA NEEDED -> FASTER)
timeout <- as.numeric(factor(no2data$riskset_id))
timein <- timeout-0.1
# COX MODEL WITHOUT INTERACTION
modelref <- coxph(Surv(timein,timeout, cc)~ basisrefno2near,
                    no2data, method="breslow", x=T)
# STEP 6: GET CUMULATIVE ESTIMATE OF ASSOCIATION AS WELL AS SINGLE LAG DAY PREDICTIONS FOR AN 






# STAGE 2: INVESTIGATION OF EFFECT MODIFICATION BY AN INDICATOR OF HEALTH THAT IS ORDINAL #
# IN THIS EXAMPLE THE SELECTED INDICATOR OF HEALTH IS THE NO. OF HOSPITALISATIONS (NHOSP) #
# AND WE WANT TO OBTAIN THE CUMULATIVE ESTIMATES OF ASSOCIATION AND 95% CI # 
# FOR AN INTERQUARTILE RANGE INCREASE IN NO2 AT NHOSP = 0 AND =5. #
#################################################################################################
# STEP 7: DEFINE INTERACTION TERMS BETWEEN NO2 AND HOSPITALISATION (NHOSP), CENTRED AT SELECTED 
VALUES OF THE INDICATOR:
basisint0 <- basisrefno2near*(no2data$nhosp)
basisint5 <- basisrefno2near*(no2data$nhosp-5)
# STEP 8: COX MODELS WITH INTERACTION
modelint0 <- coxph(Surv(timein,timeout, cc)~ basisrefno2near + nhosp + basisint0,
no2data, method="breslow", x=T)
modelint5 <- coxph(Surv(timein,timeout, cc)~ basisrefno2near + nhosp + basisint5,
 no2data, method="breslow", x=T)
# STEP 9: GENERATE PREDICTIONS FOR IQR INCREASE AT SELECTED VALUES OF THE INDICATOR FOR AN 
INTERQUARTILE INCREASE IN NO2
predint0 <- crosspred(basisrefno2near,modelint0,cen=0,at=iqr)
predint5 <- crosspred(basisrefno2near,modelint5,cen=0,at=iqr)
# STEP 10: COMPARE OVERALL CUMULATIVE HR (CAN ALSO ACCESS CONFIDENCE INTERVALS)
# HR AT NHOSP =0
c(predint0$allRRfit,predint0$allRRlow,predint0$allRRhigh)
# HR AT NHOSP =5
c(predint5$allRRfit,predint5$allRRlow,predint5$allRRhigh)
################################################################################################# 
# STAGE 3: INVESTIGATION OF EFFECT MODIFICATION BY AN INDICATOR OF HEALTH THAT IS CATEGORICAL #
# IN THIS EXAMPLE THE INDICATOR OF HEALTH IS BASED ON FUROSEMIDE (LASIX) USAGE, #
# WHICH IS A FOUR-LEVEL CATEGORICAL VARIABLE #
# AND WE WANT TO OBTAIN THE CUMULATIVE ESTIMATES OF ASSOCIATION AND 95% CI # 
# FOR AN INTERQUARTILE RANGE INCREASE IN NO2 SPECIFIC TO EACH CATEGORY #
# #
# #
# IN THE DATASET SET, FUROSEMIDE CATEGORIES ARE REPRESENTED USING THREE BINARY (CODED 0/1) #
# INDICATOR VARIABLES DEFEINED AS FURO1, FURO2, FURO3, #
# EACH OF THEM REPRESENTING A CATEGORY VS A REFERENCE IN A DUMMY PARAMETISATION #
#################################################################################################
# ESTIMATE THE ASSOCIATION FOR THE REFERENCE CATEGORY (I.E., ALL BINARY INDICATORS =0)
 
# STEP 11: CREATING INTEREACTION TERM BETWEEN EACH BINARY INDICATOR AND THE CROSS-BASIS FUNCTION 
FOR AIR POLLUTANT 
int_no2near_furo1 <- no2data$furo1* basisrefno2near
int_no2near_furo2 <- no2data$furo2* basisrefno2near
int_no2near_furo3 <- no2data$furo3* basisrefno2near
# STEP 12: COX MODEL WITH INTERACTIONS
cox_no2near_furo0<- coxph(Surv(timein,timeout, cc)~ basisrefno2near + int_no2near_furo1 + 
int_no2near_furo2 + int_no2near_furo3, no2data, method="breslow", x=T)
# STEP 13: GET PREDICTIONS FOR AN IQR INCREASE IN NO2
predrefnear0 <- crosspred(basisrefno2near,cox_no2near_furo0,cen=0,at=iqrno2near)
c(predrefnear0$allRRfit,predrefnear0$allRRlow,predrefnear0$allRRhigh)
### TO OBTAIN ESTIMATES OF ASSOCIATIONS FOR THE OTHER CATEGORIES OF FUROSEMIDE, REPEAT THE 
PROCEDURE (I.E., STEPS 11, 12 AND 13) BUT AT STEP 11 CENTER THE BINARY INDICATORS ON THE DESIRED 
CATEGORY





cox_no2near_furo1<- coxph(Surv(timein,timeout, cc)~ basisrefno2near + int_no2near_furo1 + 
int_no2near_furo2 + int_no2near_furo3, no2data, method="breslow", x=T)
predrefnear1 <- crosspred(basisrefno2near,cox_no2near_furo1,cen=0,at=iqrno2near)
c(predrefnear1$allRRfit,predrefnear1$allRRlow,predrefnear1$allRRhigh)




cox_no2near_furo2<- coxph(Surv(timein,timeout, cc)~ basisrefno2near + int_no2near_furo1 + 
int_no2near_furo2 + int_no2near_furo3, no2data, method="breslow", x=T)
predrefnear2 <- crosspred(basisrefno2near,cox_no2near_furo2,cen=0,at=iqrno2near)
c(predrefnear2$allRRfit,predrefnear2$allRRlow,predrefnear2$allRRhigh)




cox_no2near_furo3<- coxph(Surv(timein,timeout, cc)~ basisrefno2near + int_no2near_furo1 + 
int_no2near_furo2 + int_no2near_furo3, no2data, method="breslow", x=T)
predrefnear3 <- crosspred(basisrefno2near,cox_no2near_furo3,cen=0,at=iqrno2near)
c(predrefnear3$allRRfit,predrefnear3$allRRlow,predrefnear3$allRRhigh)
